Developing new methods for creating chemical bonds using electrochemistry
Late-stage C-H functionalization and C-C/N coupling enabled by new strategies for electrochemically-controlled radical formation
This study is exploring new ways to create important chemical bonds that could help make better medicines, using electricity to control the process, which might lead to exciting new treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10887653 on NIH RePORTER |
What this research studies
This research focuses on creating innovative methods for forming carbon-carbon (C-C) and carbon-nitrogen (C-N) bonds in organic compounds. By utilizing electrochemistry, the researchers aim to control the formation of reactive alkyl radicals, which can then couple with other substrates to create complex molecules. The project combines expertise in synthetic methodology and organometallic chemistry to enhance the efficiency of organic synthesis, potentially leading to the discovery of new therapeutic agents. Patients may benefit from advancements in drug development that arise from these new synthetic strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals interested in novel therapeutic agents or those with conditions that could be treated by new pharmaceuticals developed through these methods.
Not a fit: Patients who are not seeking new treatment options or who do not have conditions that require novel therapeutic interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more efficient methods for developing new medications.
How similar studies have performed: Other research has successfully integrated electrochemistry into organic synthesis, indicating that this approach has potential for significant advancements.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Sevov, Christo — Ohio State University
- Study coordinator: Sevov, Christo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.